Follicular Lymphoma Stage III
1 clinical trials · Condition
◉ Watch Follicular Lymphoma Stage III
| Record | Firm | Date |
|---|---|---|
| Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab. (NCT05788081) | Olivia Newton-John Cancer Research Institute | 2023-08-31 |
Track Follicular Lymphoma Stage III automatically
Every clearance here is in the API, with alerts when new ones post.